
Colgate-Palmolive (CL) Stock Forecast & Price Target
Colgate-Palmolive (CL) Analyst Ratings
Bulls say
Colgate-Palmolive is a strong player in the household and personal care industry, with international sales accounting for 70% of its business. Despite macro pressures and a slower start in North America, the company has a consistent track record of delivering within or above its targeted range of +3-5% for organic sales growth. While there may be some potential gross risk for 2026E EPS due to rising resin and oil-derived costs, we believe Colgate-Palmolive has the ability to mitigate this through productivity increases, pricing adjustments, and other measures. Overall, we are optimistic about the company's potential for consistent revenue growth and gains in market share in the long term.
Bears say
Colgate-Palmolive is facing several headwinds in the near-term, including FX headwinds, a potential decline in private label pet food sales, and a challenging industry landscape. The company's sustainability initiatives may help mitigate some risks, but its 2026-2028 organic sales and EPS growth targets are modest. Overall, our outlook remains negative for the stock due to potential challenges in the industry and the company's limited growth potential.
This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.
Colgate-Palmolive (CL) Analyst Forecast & Price Prediction
Start investing in Colgate-Palmolive (CL)
Order type
Buy in
Order amount
Est. shares
0 shares